These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10473089

  • 21. [Detection of telomerase activity level in human non-small-cell lung cancer].
    Yang HZ, Hu CP, Su XL.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec 28; 26(6):549-50. PubMed ID: 12536537
    [Abstract] [Full Text] [Related]

  • 22. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR.
    Ann Thorac Surg; 2006 Jun 28; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [Abstract] [Full Text] [Related]

  • 23. The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: a population-based survival analysis.
    Rueth NM, Parsons HM, Habermann EB, Groth SS, Virnig BA, Tuttle TM, Andrade RS, Maddaus MA, D'Cunha J.
    Ann Surg; 2011 Aug 28; 254(2):368-74. PubMed ID: 21617585
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical significance of heparanase activity in primary resected non-small cell lung cancer.
    Takahashi H, Ebihara S, Okazaki T, Suzuki S, Asada M, Kubo H, Sasaki H.
    Lung Cancer; 2004 Aug 28; 45(2):207-14. PubMed ID: 15246192
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
    Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR.
    Clin Cancer Res; 2002 Sep 28; 8(9):2883-9. PubMed ID: 12231532
    [Abstract] [Full Text] [Related]

  • 29. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
    Kumaki F, Kawai T, Hiroi S, Shinomiya N, Ozeki Y, Ferrans VJ, Torikata C.
    Hum Pathol; 2001 Feb 28; 32(2):188-95. PubMed ID: 11230706
    [Abstract] [Full Text] [Related]

  • 30. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M.
    Thorac Cardiovasc Surg; 2006 Feb 28; 54(1):42-6. PubMed ID: 16485188
    [Abstract] [Full Text] [Related]

  • 31. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.
    J Thorac Cardiovasc Surg; 2004 Jan 28; 127(1):87-91. PubMed ID: 14752417
    [Abstract] [Full Text] [Related]

  • 32. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
    Goodgame B, Viswanathan A, Miller CR, Gao F, Meyers B, Battafarano RJ, Patterson A, Cooper J, Guthrie TJ, Bradley J, Pillot G, Govindan R.
    Am J Clin Oncol; 2008 Feb 28; 31(1):22-8. PubMed ID: 18376223
    [Abstract] [Full Text] [Related]

  • 33. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC.
    Thorax; 2009 Mar 28; 64(3):192-6. PubMed ID: 19252018
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb 28; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH, Zell JA, Ziogas A, Anton-Culver H.
    Cancer; 2008 May 01; 112(9):2011-20. PubMed ID: 18361399
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC.
    J Thorac Cardiovasc Surg; 2007 Sep 01; 134(3):638-43. PubMed ID: 17723811
    [Abstract] [Full Text] [Related]

  • 40. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP, Miaw J, Shai SE, Chen CY.
    Eur J Cardiothorac Surg; 2004 Aug 01; 26(2):425-31. PubMed ID: 15296909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.